Drug firm AstraZeneca on Friday announced positive results from a trial of a treatment for COVID-19 symptoms. The drug, made from a combination of two antibodies, was initially developed as a treatment for those who had already been exposed to…
Read MoreFibromyalgia likely the result of autoimmune problems
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in collaboration with the University of Liverpool and the Karolinska Institute, has shown that many of the symptoms in fibromyalgia syndrome (FMS) are caused by…
Read MoreGoing with your gut can result in better decision-making than using detailed data methods, study shows
Managers who use their gut instinct together with simple decision-making strategies may make equally good, but faster, decisions as those who use data to reach an outcome, a new study has found. The report, co-authored by academics at the Business…
Read MoreImpressive result for mental health therapy
The researchers evaluated the NewAccess program, which is an Australian adaptation of the United Kingdom’s IAPT (Improving Access to Psychological Therapies) approach of delivering low intensity therapies for symptoms of depression and anxiety—and the results have underlined its effectiveness. “The…
Read MoreSurvey finds US adults are most concerned about experiencing increased anxiety as a result of COVID-19
University of Phoenix today announced Harris Poll findings regarding U.S. adults’ perceptions of the COVID-19 pandemic. The survey found more than two in five (41 percent) of Americans say they are most concerned about experiencing increased anxiety; more so than…
Read More